Cross-trial secondary analysis, steroid-naive boys aged 4 to <7 with DMD: 12-month time-to-stand velocity change was similar for vamorolone (n=28) vs prednisone (n=50) or deflazacort (n=55); CIs crossed the MCID. Height growth was spared with vamorolone; BMI rose most with it.
Secondary analysisn = 133
Clemens et al. Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial